The news
Real talk: The World Health Organization (WHO) just dropped some major guidelines, and they’re keeping it strictly focused on the kiddos. The new guidance explicitly warns that children under the age of 10 should not be prescribed obesity drugs or GLP-1 weight-loss injections like Wegovy or Mounjaro.
While most of these meds aren't even licensed for the younger crowd, some doctors have been prescribing them off-label, and drug companies are currently testing them in kids as young as six. The WHO is effectively saying, "say less" to that approach for now.
Why the caution?
It’s giving major caution for a reason. Dr. Luz De Rigil, the Director of Nutrition and Food Safety at the WHO, stated that for children under 10, they do not recommend surgery, weight-management devices, or these specific meds. It's a strong recommendation, though they aren't totally against keeping up with legitimate drug trials to see how things progress.
The main concern? We have zero idea what happens if you start these treatments at such a young age. Laurence Grummer-Strawn, head of Nutrition and Food Safety Actions, noted that we don't have evidence that these can be used as a temporary "fix" before transitioning to a healthy diet later in life. Basically, the long-term vibes are totally unknown, and the experts aren't down to experiment until the evidence is solid.
What should happen instead?
For the under-10 squad, the focus should stay on healthy eating and exercise. The WHO actually mentioned that digital tech, like activity trackers and games that get you moving, could be a W for encouraging a more active lifestyle.
The stats are highkey concerning: there are roughly 170 million obese children and adolescents worldwide, with the prevalence in the 5–9 age group quadrupling since 1990. Obesity carries real health risks, including type 2 diabetes, so finding the right, safe path is a major priority.
Why it matters
We’re currently seeing a massive surge in childhood obesity, and the pressure to find a quick fix is intense. By drawing a line for the youngest age group, the WHO is prioritizing long-term health over immediate interventions, ensuring we don't make a permanent mistake with a temporary solution.
